Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.09 USD | +12.50% | +63.64% | -10.09% |
02-06 | Marizyme, Inc. Announces Resignation of Julie Kampf from the Board of Directors | CI |
2023 | Marizyme, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
Business Summary
Number of employees: 13
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Life Science Technologies
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +176.60% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 1 | 100.0 % | +176.60% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Barthel
CEO | Chief Executive Officer | 67 | 21-11-15 |
George Kovalyov
DFI | Director of Finance/CFO | 39 | 21-12-20 |
Chairman | 71 | 21-02-21 | |
Donald Very
CTO | Chief Tech/Sci/R&D Officer | 66 | 20-12-01 |
Catherine Pachuk
CTO | Chief Tech/Sci/R&D Officer | 68 | 20-06-30 |
Harrison Ross
IRO | Public Communications Contact | 33 | 21-12-22 |
Amar Dhaduk
PRN | Corporate Officer/Principal | - | 20-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Barthel
CEO | Chief Executive Officer | 67 | 21-11-15 |
Chairman | 71 | 21-02-21 | |
Terry Brostowin
BRD | Director/Board Member | 65 | 18-12-13 |
Nilesh Patel
BRD | Director/Board Member | 59 | 22-04-21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 131,793,088 | 116,713,747 ( 88.56 %) | 0 | 88.56 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-10.09% | 11.86M | |
+9.64% | 115B | |
+11.69% | 106B | |
-2.45% | 21.96B | |
-14.24% | 21.87B | |
-5.29% | 19.21B | |
-4.45% | 18.08B | |
-38.29% | 17.71B | |
+7.39% | 14.32B | |
+35.88% | 12.42B |
- Stock Market
- Equities
- GBSX Stock
- Company Marizyme, Inc.